P/E Ratio
Updated 80h ago
Sector Performance
58th percentileGRMN
28.5x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
The P/E ratio compares a stock's price to its earnings per share — at 28.5x, investors are paying $28.50 for each dollar of GRMN's annual earnings.
Among sector peers, this ratio sits above the median of 24.8x, placing GRMN in the 58th percentile, meaning it is more expensive than about 58% of similar companies. Trend data is unavailable — the year-over-year change is listed as N/A, and the quarter-over-quarter change is also N/A, so no direction can be assessed. Without a trend, the analysis relies solely on the current level: a P/E above the sector median suggests investors expect above-average growth or are willing to pay a premium, which carries higher valuation risk if earnings disappoint. This combination — a moderately elevated multiple with no trend — points to a neutral risk profile where upside potential from growth is balanced by the risk of overvaluation. The P/E ratio neither strongly supports nor contradicts the overall NEUTRAL verdict, as it indicates a fair but not compelling entry point relative to peers.
Frequently Asked Questions
What does the P/E Ratio tell investors about GRMN?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are GRMN's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master GRMN's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full GRMN research report →GRMN
28.5x
Sector Median
24.7x
Sector Avg
36.0x
How GRMN's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.